Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 11,226 | -31,761 | 99,652 | 75,364 | 55,696 |
| Depreciation Amortization | 1,461 | 598 | -3,213 | 1,408 | 931 |
| Income taxes - deferred | -10,229 | -13,110 | -37,537 | -22,355 | -31,469 |
| Accounts receivable | -17,134 | 20,714 | -5,810 | -15,653 | -10,591 |
| Accounts payable and accrued liabilities | -25,885 | -7,644 | 25,068 | 19,070 | 8,149 |
| Other Working Capital | -36,603 | 5,294 | -1,406 | -10,591 | -13,939 |
| Other Operating Activity | 93,935 | 9,137 | 65,242 | 56,305 | 40,290 |
| Operating Cash Flow | $16,771 | $-16,772 | $141,996 | $103,548 | $49,067 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -21,971 | 4,743 | -319,607 | 81,762 | 67,117 |
| PPE Investments | -2,729 | -201 | -211 | -161 | -161 |
| Purchase Of Investment | N/A | N/A | 389,576 | N/A | N/A |
| Investing Cash Flow | $-24,700 | $4,542 | $69,758 | $81,601 | $66,956 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 15,941 | 6,521 | 25,490 | 20,168 | 15,965 |
| Common Stock Repurchased | N/A | N/A | -172,915 | -172,915 | -130,451 |
| Other Financing Activity | -17,218 | -5,761 | -72,941 | -36,403 | -28,251 |
| Financing Cash Flow | $-1,277 | $760 | $-220,366 | $-189,150 | $-142,737 |
| Exchange Rate Effect | -250 | -287 | 1,442 | 1,474 | 1,794 |
| Beginning Cash Position | 121,745 | 121,745 | 127,665 | 127,665 | 128,665 |
| End Cash Position | 112,289 | 109,988 | 120,495 | 125,138 | 103,745 |
| Net Cash Flow | $-9,456 | $-11,757 | $-7,170 | $-2,527 | $-24,920 |
| Free Cash Flow | |||||
| Operating Cash Flow | 16,771 | -16,772 | 141,996 | 103,548 | 49,067 |
| Capital Expenditure | -2,729 | -201 | -211 | -161 | -161 |
| Free Cash Flow | 14,042 | -16,973 | 141,785 | 103,387 | 48,906 |